Tirzepatide Outperforms Testosterone in Boosting Hormones and Body Composition in Obese Men: Pilot Study Medha Baranwal26 July 2025 9:00 AM ISTItaly: Tirzepatide (TZP), a dual receptor agonist for glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), may offer...
Tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide: Study Dr. Kamal Kant Kohli25 July 2025 9:15 AM ISTResearchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and...
Consuming more protein may protect patients taking anti-obesity drug from muscle loss: Study Dr. Kamal Kant Kohli24 July 2025 8:30 PM ISTWomen and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent...
Anti-obesity medications associated with weight rebound post-treatment,suggests study Dr. Kamal Kant Kohli23 July 2025 9:00 AM ISTPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis...
Weight loss drugs may help prevent stroke and reduce brain injury-related complications, studies show Dr. Kamal Kant Kohli21 July 2025 9:00 AM ISTThree studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors...
Higher the body mass index, higher the risk for complications after bariatric surgery: Study Dr. Kamal Kant Kohli20 July 2025 9:00 PM ISTThe higher a person's body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI of 50 or more,...
Anti-obesity medications can normalize testosterone levels in men, suggests study Dr. Kamal Kant Kohli20 July 2025 9:00 PM ISTAnti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to...
Obesity and type 2 diabetes in teen years can impair bone health: Study Dr. Kamal Kant Kohli20 July 2025 8:15 PM ISTObesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in...
Medical Bulletin 19/July/2025 Dr. Bhumika Maikhuri19 July 2025 3:00 PM ISTHere are the top medical news for the day:Can Having 2 Eggs in Breakfast Improve your Cholesterol Profile?Egg lovers can now enjoy their breakfast...
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study Medha Baranwal19 July 2025 9:15 AM ISTTaiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
Risk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study Dr. Kamal Kant Kohli19 July 2025 8:30 AM ISTA population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with...
